Business Practice

How will pharma companies navigate America’s new abortion laws?

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

This is the story of how DNDi put forward a new model for collaborative, open science.

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Packaging should be about patients, but how can we turn a decades-old philosophy into the status quo?

How AI can be leveraged to improve patient acquisition.

Explore the potential of AI with industry experts.